At present, the injection pen is mainly used for subcutaneous injection of various biological drugs, such as recombinant human growth hormone (drugs for dwarfism), insulin and analogs (drugs for diabetes), GLP-1 drugs (drugs for diabetes), teriparatide (osteoporosis drugs), recombinant human follicle-stimulating hormone (drugs for infertility), apomorphine (drugs for Parkinson's disease) and other chronic disease drugs that require medium- and long-term self-medication, as well as high-priced targeted drugs such as adalimumab and alirocumab, and consumer markets such as high-end beauty needles
Single nuclei transcriptomics delineates complex immune and kidney cell interactions contributing to kidney allograft fibrosis
Cagrilintide Cagrilintide is a long-acting amylin analog studied for its role in appetite regulation and metabolic signaling
On April 30, 2026, the FDA formally proposed excluding semaglutide, tirzepatide, and liraglutide from the 503B outsourcing facility bulks list (Federal Register docket 2026-08552), citing no current clinical need for outsourcing facilities to compound these drugs from bulk drug substances
Your care team will discuss management strategies with you before you take your first dose
Unlike regular anti-inflammatory drugs, BPC-157 works in multiple ways without known harmful side effects